FDA Date: 3/27/14
Zyban (bupropion hydrochloride) Sustained-Release Tablets REMS
Goals of the Zyban (bupropion hydrochloride) Sustained-Release Tablets REMS Program
The goal of this REMS is to inform patients about the potential serious risk of neuropsychiatric adverse events associated with the use of ZYBAN.
REMS Elements• Medication Guide